Experimental and Clinical Hematology Program PHEC
Acute lymphoblastic leukemia (ALL)
José María Ribera
Position at Josep Carreras Institute:
Group leaderBarcelona Endothelium Team (BET)
Enric Carreras
Position at Josep Carreras Institute:
Group leaderMyeloid neoplasms
Lurdes Zamora
Position at Josep Carreras Institute:
Group leaderImmunohematology and glycobiology
Fumiichiro Yamamoto
Position at Josep Carreras Institute:
Group leaderLeukemia stem cell group
Ruth Muñoz Risueño
Position at Josep Carreras Institute:
Group leaderLymphoid neoplasms
Tomás Navarro
Position at Josep Carreras Institute:
Group leaderMultiple myeloma
Albert Oriol
Position at Josep Carreras Institute:
Group leaderMyelodysplastic syndromes
Francesc Solé
Position at Josep Carreras Institute:
Group leaderStem cell biology, developmental leukemia and immunotherapy
Pablo Menéndez
Position at Josep Carreras Institute:
Group leaderStem cell transplantation and cellular Immunotherapy
Álvaro Urbano-Ispizua
Position at Josep Carreras Institute:
Group leaderEpigenetic therapies
María Berdasco
Position at Josep Carreras Institute:
Group leaderLymphoma translational group
Gaël Roué
Position at Josep Carreras Institute:
Group leaderOncogenesis and antitumor drugs
Ramon Mangues
Position at Josep Carreras Institute:
Group leaderChronic lymphocytic leukemia
Carolina Moreno
Position at Josep Carreras Institute:
Group leaderHematological diseases, transplant, and cell therapy
Jordi Sierra
Position at Josep Carreras Institute:
Group leaderMyeloid neoplasms - Clínic
Jordi Esteve Reyner
Position at Josep Carreras Institute:
Group leaderHematology
David Gallardo
Position at Josep Carreras Institute:
Group leaderDescriptive and analytical epidemiology of cancer
Rafael Marcos-Grajera
Position at Josep Carreras Institute:
Group leaderCellular immunotherapy and gene therapy group
Javier Briones
Position at Josep Carreras Institute:
Group leaderHematological diagnosis
Josep Nomdedéu